Pendulum
3 employees
Biotech
Series C · $111.0M
Open positions (5)
Company details
Team Size3
IndustryBiotech
Funding
Total raised
$111.0M
Last stage
Series C
Investors
True Ventures
Total raised
$111.0M
Last stage
Series C
Investors
James H. Bullard
Co-founder and CTO of Pendulum Therapeutics. Previously worked at Pacific Biosciences alongside fellow co-founders.
John Eid
Led technology development teams for nearly two decades across advanced microscopy, genome sequencing, and biophysical systems. Previously principal scientist at Pacific Biosciences. PhD in Biophysics and Computational Biology from University of Illinois, Urbana-Champaign.
Colleen Cutcliffe
PhD in Biochemistry and Molecular Biology from Johns Hopkins University. Over 20 years of experience in biotech, pharma, and academia. Previously Senior Manager of Biology at Pacific Biosciences.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.